Please sign in to follow a disease.
Leukodystrophy
MONDO:0019046Leukodystrophies are a group of rare, progressive, metabolic, genetic diseases that affect the brain, spinal cord and often the peripheral nerves. Each type of leukodystrophy is caused by a specific gene abnormality that leads to abnormal development or destruction of the white matter (myelin sheath) of the brain. The myelin sheath is the protective covering of the nerve and nerves can't function normally without it. Each type of leukodystrophy affects a different part of the myelin sheath, leading to a range of neurological problems.
Also known as: hypomyelinating leukodystrophy, hypomyelinating leukoencephalopathy, leukodystrophy, hypomyelinating
72 clinical trials for this condition and its sub-types, 6 tagged with Leukodystrophy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Leukodystrophy
-
Metachromatic leukodystrophy 20 trials
2 sub-types
- Metachromatic leukodystrophy, juvenile form 2 trials · 4 incl. sub-types Sub-types →
- Metachromatic leukodystrophy due to saposin B deficiency 0 trials
-
Adrenoleukodystrophy 19 trials · 20 incl. sub-types
3 sub-types
- Adrenomyeloneuropathy 7 trials
- X-linked cerebral adrenoleukodystrophy 4 trials
- Isolated adrenal insufficiency 0 trials
-
Krabbe disease 15 trials
3 sub-types
- Infantile Krabbe disease 2 trials
- Adult Krabbe disease 0 trials
- Late-infantile/juvenile Krabbe disease 0 trials
-
Aicardi-Goutieres syndrome 9 trials
10 sub-types
- Aicardi-Goutieres syndrome 1 2 trials Sub-types →
- Aicardi-Goutieres syndrome 2 0 trials
- Aicardi-Goutieres syndrome 3 0 trials
- Aicardi-Goutieres syndrome 4 0 trials
- Aicardi-Goutieres syndrome 5 0 trials
- Aicardi-Goutieres syndrome 6 0 trials
- Aicardi-Goutieres syndrome 7 0 trials
- Aicardi-Goutieres syndrome 8 0 trials
- Aicardi-Goutieres syndrome 9 0 trials
- Basal ganglia calcification, idiopathic, childhood-onset 0 trials
-
5 sub-types
- Null syndrome 2 trials
- Pelizaeus-Merzbacher disease in female carriers 0 trials
- Pelizaeus-Merzbacher disease, classic form 0 trials
- Pelizaeus-Merzbacher disease, connatal form 0 trials
- Pelizaeus-Merzbacher disease, transitional form 0 trials
-
Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types
2 sub-types
- Zellweger spectrum disorders 6 trials · 7 incl. sub-types Sub-types →
- Non-Zellweger spectrum disorder 0 trials · 1 incl. sub-types Sub-types →
-
9 sub-types
- Leukoencephalopathy with vanishing white matter 1 3 trials
- Congenital or early infantile CACH syndrome 0 trials
- Juvenile or adult CACH syndrome 0 trials
- Late infantile CACH syndrome 0 trials
- Leukoencephalopathy with vanishing white matter 2 0 trials
- Leukoencephalopathy with vanishing white matter 3 0 trials
- Leukoencephalopathy with vanishing white matter 4 0 trials
- Leukoencephalopathy with vanishing white matter 5 0 trials
- Leukoencephalopathy, progressive, with ovarian failure 0 trials
-
Canavan disease 6 trials
2 sub-types
- Mild Canavan disease 0 trials
- Severe Canavan disease 0 trials
-
Cerebrotendinous xanthomatosis 6 trials
-
Alexander disease 5 trials
2 sub-types
- Alexander disease type I 0 trials
- Alexander disease type II 0 trials
-
Sjogren-Larsson syndrome 3 trials
-
Leukodystrophy, demyelinating, adult-onset 0 trials · 3 incl. sub-types
1 sub-type
-
Hypomyelinating leukodystrophy 5 2 trials
-
Hypomyelinating leukodystrophy 6 2 trials
-
Pelizaeus-Merzbacher-like disease 1 trial · 2 incl. sub-types
3 sub-types
- Hypomyelinating leukodystrophy 2 1 trial
- Hypomyelinating leukodystrophy 3 0 trials
- Hypomyelinating leukodystrophy 4 0 trials
-
POLR-related leukodystrophy 0 trials · 2 incl. sub-types
2 sub-types
- POLR3-related leukodystrophy 0 trials · 2 incl. sub-types Sub-types →
- Leukodystrophy, hypomyelinating, 27 0 trials
-
AARS1-related leukoencephalopathy 0 trials
3 sub-types
-
CADDS 0 trials
-
Alkaline ceramidase 3 deficiency 0 trials
-
Dermatoleukodystrophy 0 trials
-
Hereditary spastic paraplegia 2 0 trials
-
Hypomyelinating leukodystrophy 10 0 trials
-
Hypomyelinating leukodystrophy 12 0 trials
-
Hypomyelinating leukodystrophy 13 0 trials
-
Hypomyelinating leukodystrophy 9 0 trials
-
Leukodystrophy, hypomyelinating, 14 0 trials
-
Leukodystrophy, hypomyelinating, 15 0 trials
-
Leukodystrophy, hypomyelinating, 16 0 trials
-
Leukodystrophy, hypomyelinating, 17 0 trials
-
Leukodystrophy, hypomyelinating, 18 0 trials
-
Leukodystrophy, hypomyelinating, 20 0 trials
-
Leukodystrophy, hypomyelinating, 22 0 trials
-
Leukodystrophy, hypomyelinating, 24 0 trials
-
Leukodystrophy, hypomyelinating, 25 0 trials
-
Leukodystrophy, hypomyelinating, 28 0 trials
-
Ravine syndrome 0 trials
-
Ribose-5-P isomerase deficiency 0 trials
-
Unknown leukodystrophy 0 trials
Most studied deeper sub-types
-
Can Gene-Modified stem cells stop a devastating brain disease?
Cure Not yet recruitingThis trial tests a gene therapy for metachromatic leukodystrophy (MLD), a rare inherited disease that damages the nervous system. Researchers take a patient's own blood stem cells, add a corrected gene, and infuse them back. The goal is to see if this approach is safe and can slo…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Cure
Last updated Sep 03, 2026 00:00 UTC
-
Experimental gene therapy aims to halt fatal brain disease in children
Disease control Not yet recruitingThis trial tests a gene therapy for X-linked adrenoleukodystrophy (X-ALD), a rare genetic disease that damages the brain. The therapy uses a modified virus to deliver a working copy of the faulty gene directly into the spinal fluid and bloodstream. Up to 30 patients aged 1 year a…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Gene therapy aims to halt fatal brain disease in children
Disease control Not yet recruitingThis trial tests a gene therapy for metachromatic leukodystrophy (MLD), a rare and life-threatening genetic disorder that damages the nervous system. The treatment uses a lentivirus to deliver a working copy of the ARSA gene directly into the spinal fluid and bloodstream. Up to 1…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a repurposed drug slow rare childhood brain diseases?
Disease control Not yet recruitingThis phase 2 trial is testing an oral drug called PLX-200 (gemfibrozil) in children aged 2 to 15 with certain lysosomal storage disorders (LSDs), including CLN2, CLN3, Sandhoff disease, and Krabbe disease. The study aims to see if the drug is safe, tolerable, and may slow the pro…
Phase 2 • Sponsor: Polaryx Therapeutics, Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a simple gel boost gum healing in diabetes?
Disease control Not yet recruitingThis study tests whether adding hyaluronic acid gel to standard deep cleaning (scaling and root planing) improves gum healing in people with both diabetes and advanced gum disease. Twenty-three participants will receive the standard cleaning on all teeth, and then two gum pockets…
Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Robot suit aims to get kids with disabilities walking
Symptom relief Not yet recruitingThis study tests a robotic exoskeleton called CLINICAL EXPLORER in 60 children aged 2 to 17 with neurodevelopmental disorders like cerebral palsy. The device supports walking during 8 therapy sessions. Researchers will check if it is safe, easy to use, and helps improve movement …
Sponsor: MarsiBionics • Aim: Symptom relief
Last updated Jun 26, 2026 14:47 UTC
-
Could pomegranate supplements help heal the gut in Alcohol-Related liver disease?
Knowledge-focused Not yet recruitingThis study investigates how pomegranate dietary supplements influence gut bacteria and inflammation in people with alcohol use disorder and alcohol-related liver disease. Researchers will measure levels of beneficial gut metabolites called urolithins and inflammatory markers in b…
Sponsor: University of Louisville • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC